Shouldn’t we expect low volume? Until there is a meaningful PR or uplisting, I would think the buyers have bought and the sellers have sold. The pps seems to have settled between 2.00 and 2.10. Low volume and price volatility is welcome at this point. Yesterday’s update indicates “a number of new announcements” “over the coming weeks”. Presumably these will be made prior to uplisting. That should make things interesting.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links